Autoren
Paul England

Paul England, DPhil

Senior Professional Support Lawyer

Read More
Rhys Bufton

Rhys Bufton

Senior Associate

Read More
Autoren
Paul England

Paul England, DPhil

Senior Professional Support Lawyer

Read More
Rhys Bufton

Rhys Bufton

Senior Associate

Read More

1. Juni 2018

Synapse - law for life sciences - May 2018

This month on Synapse

Blockchain technology in the life sciences and healthcare industries

Alex Walker explains what block chain technology is and how the life sciences and healthcare industries stand to benefit from it.

Topical issues

Choosing the right space for life science success

Raman Sharma, Rhys Bufton and Lucy Sharples discuss how to choose among the various letting strategies available in the life sciences space.

GC finds Normon similar to Normosang for pharmaceuticals

The General Court has upheld a decision of the Board of Appeal that the marks Normon and Normosang, both covering pharmaceutical products, are confusingly similar.

AG's Opinion on how a product must be identified by a patent for SPC protection

Paul England brings news of the latest SPC development, the Ag's Opinion on whether or not Truvada (a combination of tenofovir disoproxil and emtricitabine) is protected by a patent claiming tenofovir disoproxil and ̔optionally other therapeutic ingredients.

The UK has ratified the UPC Agreement

After delay, the UK has ratified the UPC Agreement. What next?

Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Life Sciences & Healthcare

Synapse - December 2019

19. Dezember 2019

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Healthcare

Cannabis: what's new for the 6000 year old medicine?

8. November 2018

von Paul England, DPhil

Klicken Sie hier für Details